Home › Stocks › ATRA › All Fund Holders
ATRA — ATARA BIOTHERAPEUTICS INC · All Fund Holders
Funds holding (latest): 40 · Reported value held: $39.63M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Maverick Capital history | Q3 2023 | 6.47M | $9.58M | 0.22% | Hold |
| Point72 Asset Management history | Q2 2026 | 687.72K | $7.90M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 225.94K | $4.09M | 0.00% | Add |
| PSP Investments history | Q4 2021 | 201.00K | $3.17M | 0.02% | Add |
| Norges Bank Investment Management history | Q4 2022 | 868.66K | $2.85M | 0.00% | New |
| Arrowstreet Capital history | Q3 2022 | 721.61K | $2.73M | 0.00% | Add |
| Marshall Wace history | Q4 2025 | 148.63K | $2.69M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 84.45K | $969.54K | 0.00% | Add |
| CPP Investments history | Q1 2022 | 104.00K | $966.00K | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 75.13K | $862.92K | 0.00% | Add |
| Renaissance Technologies history | Q4 2025 | 30.04K | $543.42K | 0.00% | Add |
| D. E. Shaw & Co history | Q4 2023 | 1.03M | $530.23K | 0.00% | Reduce |
| Prudential Financial history | Q2 2024 | 36.34K | $308.89K | 0.00% | New |
| BNY Mellon history | Q1 2024 | 352.51K | $244.64K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2024 | 26.16K | $222.32K | 0.00% | Reduce |
| Balyasny Asset Management history | Q3 2022 | 58.47K | $221.00K | 0.00% | Add |
| Manulife Financial history | Q1 2024 | 312.16K | $216.64K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 16.59K | $190.47K | 0.00% | Add |
| Bank of America Corp history | Q4 2025 | 10.39K | $187.90K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 16.24K | $186.41K | 0.00% | Hold |
| Goldman Sachs Group history | Q1 2024 | 244.26K | $169.51K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 12.68K | $145.57K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2024 | 15.08K | $128.17K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 10.16K | $116.62K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 9.18K | $105.37K | 0.00% | Hold |
| Janus Henderson Group history | Q1 2023 | 32.83K | $95.04K | 0.00% | Add |
| Two Sigma Investments history | Q4 2023 | 129.18K | $66.25K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 3.98K | $45.68K | 0.00% | Reduce |
| Deutsche Bank AG history | Q1 2024 | 36.35K | $25.08K | 0.00% | Reduce |
| Invesco Ltd history | Q1 2024 | 34.51K | $23.95K | 0.00% | Hold |
| Amundi US history | Q1 2023 | 7.34K | $20.40K | 0.00% | Hold |
| Principal Global Investors history | Q1 2024 | 26.59K | $18.45K | 0.00% | Reduce |
| Franklin Resources history | Q4 2023 | 23.03K | $11.81K | 0.00% | Hold |
| Legal & General Investment Management America history | Q1 2024 | 9.05K | $6.28K | 0.00% | Hold |
| T. Rowe Price Associates history | Q1 2024 | 4.96M | $3.44K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 251 | $2.88K | 0.00% | Hold |
| JPMorgan Chase & Co history | Q2 2026 | 216 | $2.41K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 97 | $1.11K | 0.00% | Add |
| PNC Financial Services history | Q4 2023 | 59 | $30 | 0.00% | New |
| Lazard Asset Management history | Q1 2025 | 368 | $2 | 0.00% | Reduce |